News headlines about Edap Tms (NASDAQ:EDAP) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Edap Tms earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave press coverage about the medical equipment provider an impact score of 46.18936643813 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Here are some of the media headlines that may have impacted Accern’s rankings:
- Urology Lasers Market Enhancement in Medical Sector 2018 to 2025 (sbwire.com)
- Global High-intensity Focused Ultrasound (HIFU) Therapy Market (2018-2025) to Grow at a CAGR of 21.8 … (thedailytimes.com)
- Are you looking for sizzling stock?: EDAP TMS SA (EDAP), Kewaunee Scientific Corporation (KEQU) (newsregistrar.com)
- Analysts Anticipate Edap Tms SA (EDAP) to Announce ($0.02) Earnings Per Share (americanbankingnews.com)
Shares of Edap Tms remained flat at $$3.14 during midday trading on Friday, MarketBeat.com reports. The stock had a trading volume of 19,752 shares, compared to its average volume of 63,877. The company has a market capitalization of $91.05 million, a P/E ratio of -314.00 and a beta of 0.62. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.04 and a current ratio of 2.45. Edap Tms has a 1 year low of $2.07 and a 1 year high of $4.25.
EDAP has been the topic of several analyst reports. HC Wainwright reissued a “buy” rating and issued a $6.50 target price on shares of Edap Tms in a report on Monday, July 2nd. ValuEngine raised Edap Tms from a “hold” rating to a “buy” rating in a report on Monday, July 16th. Finally, TheStreet downgraded Edap Tms from a “c” rating to a “d+” rating in a report on Tuesday, May 15th.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Further Reading: How to Use the New Google Finance Tool
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.